Gastroenterology
Volume 131, Issue 4 , Pages 1030-1039, October 2006

Relative Contribution of Genetic and Nongenetic Modifiers to Intestinal Obstruction in Cystic Fibrosis

  • Scott M. Blackman

      Affiliations

    • McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    • Pediatric Endocrinology Division, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
  • ,
  • Rebecca Deering–Brose

      Affiliations

    • McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    • Human Genetics and Molecular Biology Predoctoral Program, Johns Hopkins University School of Medicine, Baltimore, Maryland
  • ,
  • Rita McWilliams

      Affiliations

    • McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    • Rutgers University and the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick, New Jersey
    • Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland
  • ,
  • Kathleen Naughton

      Affiliations

    • McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
  • ,
  • Barbara Coleman

      Affiliations

    • McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
  • ,
  • Teresa Lai

      Affiliations

    • McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
  • ,
  • Marilyn Algire

      Affiliations

    • McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
  • ,
  • Suzanne Beck

      Affiliations

    • St. Christopher’s Hospital for Children and the Department of Pediatrics, Drexel University College of Medicine, Philadelphia, Pennsylvania
  • ,
  • Julie Hoover-Fong

      Affiliations

    • McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
  • ,
  • Ada Hamosh

      Affiliations

    • McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
  • ,
  • M. Daniele Fallin

      Affiliations

    • Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland
  • ,
  • Kristen West

      Affiliations

    • McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
  • ,
  • Dan E. Arking

      Affiliations

    • McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
  • ,
  • Aravinda Chakravarti

      Affiliations

    • McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
  • ,
  • David J. Cutler

      Affiliations

    • McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
  • ,
  • Garry R. Cutting

      Affiliations

    • McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    • Corresponding Author InformationAddress requests for reprints to: Garry R. Cutting, MD, BRB 559, Johns Hopkins Medical Institutions, 733 North Broadway, Baltimore, Maryland 21287. fax: (410) 614-0213.
  • ,
  • CF Twin and Sibling Study

Received 22 September 2005; accepted 28 June 2006. published online 25 July 2006.

Background & Aims: Neonatal intestinal obstruction (meconium ileus [MI]) occurs in 15% of patients with cystic fibrosis (CF). Our aim was to determine the relative contribution of genetic and nongenetic modifiers to the development of this major complication of CF. Methods: A total of 65 monozygous twin pairs, 23 dizygous twin/triplet sets, and 349 sets of siblings with CF were analyzed for MI status, significant covariates, and genome-wide linkage. Results: Specific mutations in the CF transmembrane conductance regulator (CFTR), the gene responsible for CF, correlated with MI, indicating a role for CFTR genotype. Monozygous twins showed substantially greater concordance for MI than dizygous twins and siblings (P = 1 × 10−5), showing that modifier genes independent of CFTR contribute substantially to this trait. Regression analysis revealed that MI was correlated with distal intestinal obstruction syndrome (P = 8 × 10−4). Unlike MI, concordance analysis indicated that the risk for development of distal intestinal obstruction syndrome in CF patients is caused primarily by nongenetic factors. Regions of suggestive linkage (logarithm of the odds of linkage >2.0) for modifier genes that cause MI (chromosomes 4q35.1, 8p23.1, and 11q25) or protect from MI (chromosomes 20p11.22 and 21q22.3) were identified by genome-wide analyses. These analyses did not support the existence of a major modifier gene on chromosome 19 in a region previously linked to MI. Conclusions: The CFTR gene along with 2 or more modifier genes are the major determinants of intestinal obstruction in newborn CF patients, whereas intestinal obstruction in older CF patients is caused primarily by nongenetic factors.

Abbreviations used in this paper: CF, cystic fibrosis, CFTR, cystic fibrosis transmembrane conductance regulator, DIOS, distal intestinal obstruction syndrome, DZ, dizygous, LOD, logarithm of odds of linkage, MI, meconium ileus, MZ, monozygous, PI, pancreatic insufficiency, PS, pancreatic sufficiency, SNP, single nucleotide polymorphism, STR, short tandem repeat

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by grant HL 68927 from the National Institute of Heart, Lung and Blood, by grant CUTTIN00A0 from the US Cystic Fibrosis Foundation, by T32 DK07751 from the National Institute of Digestive and Diabetes and Kidney Disease (S.B.), and by T32 GM007814 from the National Institute of General Medical Sciences (R.D.-B.).

PII: S0016-5085(06)01659-3

doi:10.1053/j.gastro.2006.07.016

Gastroenterology
Volume 131, Issue 4 , Pages 1030-1039, October 2006